DB-3Q for the Treatment of Medically Refractory Crohn's Disease
DB-3Q for the Treatment of Medically Refractory Crohn's Disease
Recruiting · NCT07625293 · Registry updated 2026-09-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DB-3Q for the Treatment of Medically Refractory Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Phase 2 | 2026-09-01 | NCT07625293 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Direct Biologics, LLC | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Washington University, St. Louis | St Louis | United States | 10 |